VOXILAPREVIR | VOXILAPREVIR | ATC J05AP56
ANTIINFECTIVES TREATMENT OF HEPATITIS C VIRUS (HCV) NS3/4A PROTEASE INHIBITOR (KI=38-66 PICOMOLAR) | ORAL | Cmax 221 NANOMOLAR Tmax 4 HOUR PPB 99 PERCENT HT 33 HOUR SOLUBILITY IS PRACTICALLY INSOLUBLE (LESS THAN 0.1 MG/ML) BELOW PH 6.8 | NS3/4A PROTEASE PDB 6NZT (CRYSTAL STRUCTURE OF HCV NS3, 4A PROTEASE IN COMPLEX WITH VOXILAPREVIR) LIGAND CODE = L9P (link to the list of PDB complexes) Download experimental 3D coordinates of L9P with added hydrogens | Genome polyprotein UNIPROT P26663 -- Genome polyprotein UNIPROT Q81495 more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |